ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Stability Indicating RP-HPLC Method for Simultaneous Determination of Pyrimethamine and Sulfamethoxypyrazine in Pharmaceutical Formulation: Application to Method Validation

Shankaranahalli Gurusiddappa Keshava,Gurupadayya Bannimath,Prachi Raikar,Maruthi Reddy.



Abstract
Download PDF Cited by 5 ArticlesPost

The present work takes into account the development of RP-HPLC for simultaneous method estimation and validation of pyrimethamine and sulfamethoxypyrazine in pharmaceutical formulation. The chromatographic separation was accomplished on C8 column by using acetonitrile and potassium dihydrogen phosphate as the mobile phase (60:40 v/v) having a flow rate of 0.8 mL/min. The eluent was detected at 254nm, simultaneously for both the drugs. The retention time for pyrimethamine and sulfamethoxypyrazine was found to be 3.33 min and 4.21 min respectively. According to the ICH guidelines the develop method was validated in terms of accuracy, precision, linearity, limit of detection, limit of quantitation, robustness and stress degradation studies. This validated method can be suggested for the routine simultaneous laboratory analysis of pyrimethamine and sulfamethoxypyrazine.

Key words: Pyrimethamine (PYR), Sulfamethoxypyrazine (SLP), RP-HPLC, ICH guidelines







Bibliomed Article Statistics

15
23
26
35
26
40
33
30
23
23
20
16
R
E
A
D
S

7

18

10

16

11

26

23

17

15

10

11

7
D
O
W
N
L
O
A
D
S
010203040506070809101112
2025

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.